Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC15878 Atractyloside Dipotassium Salt Inhibitor of ADP/ATP translocases Atractyloside Dipotassium Salt  Chemical Structure
  3. GC72319 Atrosab Atrosab is a humanized IgG1 antagonistic anti-TNFR1 antibody. Atrosab  Chemical Structure
  4. GC39699 Aurintricarboxylic acid Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively. Aurintricarboxylic acid  Chemical Structure
  5. GC46895 Aurintricarboxylic Acid (ammonium salt)

    ATA

    A protein synthesis inhibitor with diverse biological activities Aurintricarboxylic Acid (ammonium salt)  Chemical Structure
  6. GC13332 Aurora A Inhibitor I A potent and selective inhibitor of Aurora A kinase Aurora A Inhibitor I  Chemical Structure
  7. GC15295 AUY922 (NVP-AUY922)

    VER-52296, AUY-922, AUY 922, Luminespib

    AUY922 (NVP-AUY922) is a potent and selective inhibitor of HSP90, effectively inhibiting both HSP90α and HSP90β with similar IC50 values of 13nM and 21nM, respectively. AUY922 (NVP-AUY922)  Chemical Structure
  8. GC31719 Avelumab (Anti-Human PD-L1, Human Antibody) Avelumab (Anti-Human PD-L1, Human Antibody) is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity. Avelumab (Anti-Human PD-L1, Human Antibody)  Chemical Structure
  9. GC72858 Avenanthramide A Avenanthramide A is a ptoalexin, which can be found in oats (Avena sativa L. Avenanthramide A  Chemical Structure
  10. GC42880 Avenanthramide-C methyl ester Avenanthramide-C methyl ester is an inhibitor of NF-κB activation that acts by blocking the phosphorylation of IKK and IκB (IC50 ~ 40 μM). Avenanthramide-C methyl ester  Chemical Structure
  11. GC35440 AX-024 AX-024 is an orally available, first-in-class inhibitor of the TCR-Nck interaction that selectively inhibits TCR-triggered T cell activation with an IC50 ~1 nM. AX-024  Chemical Structure
  12. GC19046 AX-024 hydrochloride AX-024 hydrochloride is an cytokine release inhibitor which can strongly inhibit the production of interleukin-6 (IL-6), tumor necrosis factor-α (TNFα), interferon-γ (IFN-γ), IL-10 and IL-17A. AX-024 hydrochloride  Chemical Structure
  13. GC17045 AXL1717

    AXL 1717, NSC 36407, Picropodophyllin, PPP

    A potent and selective inhibitor of IGF-1R AXL1717  Chemical Structure
  14. GC15055 AZ 628

    AZ-628; AZ628

    Raf kinases,potent and ATP-competitive

    AZ 628  Chemical Structure
  15. GC13433 AZ 960 A JAK2 inhibitor AZ 960  Chemical Structure
  16. GC72868 AZA197 AZA197 is a selective small molecule inhibitor of Cdc42. AZA197  Chemical Structure
  17. GC46901 Azadirachtin A naturally-occurring insecticide Azadirachtin  Chemical Structure
  18. GC15033 Azathioprine

    Azamune, Azoran, BW 57322, Imuran, NSC 39084

    purine synthesis and GTP-binding protein Rac1 activation inhibitor Azathioprine  Chemical Structure
  19. GC48971 AZD 1152 (hydrochloride)

    Barasertib

    A prodrug for a potent Aurora B inhibitor AZD 1152 (hydrochloride)  Chemical Structure
  20. GC18566 AZD 3147 A dual mTORC1/mTORC2 inhibitor AZD 3147  Chemical Structure
  21. GC50109 AZD 5582 dihydrochloride Dimeric Smac mimetic; potent IAP inhibitor AZD 5582 dihydrochloride  Chemical Structure
  22. GC33247 AZD-5991 An Mcl-1 inhibitor AZD-5991  Chemical Structure
  23. GC33283 AZD-5991 Racemate AZD-5991 Racemate is the racemate of AZD-5991. AZD-5991 Racemate is a Mcl-1 inhibitor with an IC50 of <3 nM in FRET assay. AZD-5991 Racemate  Chemical Structure
  24. GC33239 AZD-5991 S-enantiomer AZD-5991 S-enantiomer is the less active enantiomer of AZD-5991. AZD-5991 S-enantiomer is a Mcl-1 inhibitor with an IC50 of 6.3 μM in FRET assay and a Kd of 0.98 μM in surface plasmon resonance (SPR) assay. AZD-5991 S-enantiomer  Chemical Structure
  25. GC64938 AZD-7648 AZD-7648 is a potent, orally active, selective DNA-PK inhibitor with an IC50 of 0.6 nM. AZD-7648 induces apoptosis and shows antitumor activity. AZD-7648  Chemical Structure
  26. GC12660 AZD1208

    AZD 1208;AZD-1208

    AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor, with IC50 values of 0.4, 5, and 1.9nM for PIM1, PIM2, and PIM3, respectively. AZD1208  Chemical Structure
  27. GC13029 AZD2014

    AZD 2014; AZD-2014

    AZD2014 (AZD2014) is an ATP competitive mTOR inhibitor with an IC50 of 2.81 nM. AZD2014 inhibits both mTORC1 and mTORC2 complexes. AZD2014  Chemical Structure
  28. GC33255 AZD4320 AZD4320 is a novel BH3-mimicking dual BCL2/BCLxL inhibitor with IC50s of 26 nM, 17 nM, and 170 nM for KPUM-MS3, KPUM-UH1, and STR-428 cells, respectively. AZD4320  Chemical Structure
  29. GC73016 AZD4877 AZD4877 is another isostere to Ispinesib and also a kinesin spindle protein (Eg5) inhibitor with IC50 of 2 nM. AZD4877  Chemical Structure
  30. GC19050 AZD5582 AZD5582 is a novel class of dimeric Smac mimetics as potent IAP antagonist; binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, respectively). AZD5582  Chemical Structure
  31. GC16380 AZD8055

    CCG-168

    AZD8055 is a new ATP-competitive mTOR inhibitor with an IC50 of 0.8 nmol/L and a Ki of 1.3 nmol/L.

    AZD8055  Chemical Structure
  32. GC19054 Azoramide Azoramide is a small-molecule modulator of the unfolded protein response with antidiabetic activity. Azoramide  Chemical Structure
  33. GC46904 Azoxystrobin

    ICI-A 5504

    A broad-spectrum fungicide Azoxystrobin  Chemical Structure
  34. GC60616 AZT triphosphate

    3'-Azido-3'-deoxythymidine-5'-triphosphate

    AZT triphosphate (3'-Azido-3'-deoxythymidine-5'-triphosphate) is a active triphosphate metabolite of Zidovudine (AZT). AZT triphosphate  Chemical Structure
  35. GC60617 AZT triphosphate TEA

    3'-Azido-3'-deoxythymidine-5'-triphosphate TEA

    AZT triphosphate TEA (3'-Azido-3'-deoxythymidine-5'-triphosphate TEA) is a active triphosphate metabolite of Zidovudine (AZT). AZT triphosphate TEA  Chemical Structure
  36. GC35458 Bacopaside II A triterpene glycoside Bacopaside II  Chemical Structure
  37. GC72817 BAI1 hydrochloride BAI1 drochloride is a selective apoptosis factor BAX allosteric inhibitors. BAI1 hydrochloride  Chemical Structure
  38. GC34263 Bak BH3 Bak BH3 is derived from the BH3 domain of Bak, can antagonize the function of Bcl-xL in cells. Bak BH3  Chemical Structure
  39. GC52344 Bak BH3 (72-87) (human) (trifluoroacetate salt) A Bak-derived peptide Bak BH3 (72-87) (human) (trifluoroacetate salt)  Chemical Structure
  40. GC12053 BAM7

    BAM 7;BAM-7

    A direct activator of Bax BAM7  Chemical Structure
  41. GN10507 Baohuoside I

    Icariin II, Icariside II

    Baohuoside I, a flavonoid isolated from Epimedium koreanum Nakai, acts as an inhibitor of CXCR4, downregulates CXCR4 expression, induces apoptosis and shows anti-tumor activity. Baohuoside I  Chemical Structure
  42. GC15371 Bardoxolone

    Bardoxolone, RTA 401

    An anti-inflammatory compound that activates Nrf2/ARE signaling Bardoxolone  Chemical Structure
  43. GC11572 Bardoxolone methyl

    Bardoxolone methyl, NSC 713200, RTA 402, TP155

    A synthetic triterpenoid with potent anticancer and antidiabetic activity Bardoxolone methyl  Chemical Structure
  44. GC60620 Batabulin Batabulin (T138067) is an antitumor agent, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization. Batabulin affects cell morphology and leads to cell-cycle arrest ultimately induces apoptotic cell death. Batabulin  Chemical Structure
  45. GC60621 Batabulin sodium

    T138067

    An inhibitor of tubulin polymerization Batabulin sodium  Chemical Structure
  46. GC68729 Bax activator-1

    Bax activator-1 (compound 106) is a Bax activator that induces Bax-dependent apoptosis in tumor cells.

    Bax activator-1  Chemical Structure
  47. GC12763 Bax channel blocker Bax channel blocker  Chemical Structure
  48. GC16023 Bax inhibitor peptide P5 Bax inhibitor Bax inhibitor peptide P5  Chemical Structure
  49. GC17195 Bax inhibitor peptide V5

    BIP-V5; BAX Inhibiting Peptide V5

    A Bax inhibitor Bax inhibitor peptide V5  Chemical Structure
  50. GC52476 Bax Inhibitor Peptide V5 (trifluoroacetate salt)

    BIP V5, VPMLK

    A Bax inhibitor Bax Inhibitor Peptide V5 (trifluoroacetate salt)  Chemical Structure
  51. GC16695 Bax inhibitor peptide, negative control Peptide inhibit Bax translocation to mitochondria Bax inhibitor peptide, negative control  Chemical Structure
  52. GC10345 Bay 11-7085

    NK-κB activation inhibitor

    Bay 11-7085  Chemical Structure
  53. GC13035 Bay 11-7821

    BAY 11-7082

    Bay 11-7821(BAY 11-7082) is an inhibitor of IκBα phosphorylation and NF-κB, selectively and irreversibly inhibits TNF-α-induced IκB-α phosphorylation (IC50 value is approximately 10μM), and reduces the expression of NF-κB and adhesion molecules. Bay 11-7821 inhibits ubiquitin-specific proteases USP7 and USP21 with IC50 values of 0.19 and 0.96μM, respectively . Bay 11-7821  Chemical Structure
  54. GC73719 BAY 1892005 BAY 1892005 is a regulator of p53 protein and acts on p53 condensates without causing mutant p53 reactivation. BAY 1892005  Chemical Structure
  55. GC73918 BAY 249716 BAY 249716 stabilizes all three p53 protein variants. BAY 249716  Chemical Structure
  56. GC16389 BAY 61-3606 A Syk inhibitor BAY 61-3606  Chemical Structure
  57. GC42897 BAY 61-3606 (hydrochloride) BAY 61-3606 is a cell-permeable, reversible inhibitor of spleen tyrosine kinase (Syk; Ki = 7.5 nM; IC50 = 10 nM). BAY 61-3606 (hydrochloride)  Chemical Structure
  58. GC12136 BAY 61-3606 dihydrochloride

    BAY61-3606 dihydrochloride;BAY 61-3606

    BAY 61-3606 dihydrochloride  Chemical Structure
  59. GC62164 BAY1082439 BAY1082439 is an orally bioavailable, selective PI3Kα/β/δ inhibitor. BAY1082439 also inhibits mutated forms of PIK3CA. BAY1082439 is highly effective in inhibiting Pten-null prostate cancer growth. BAY1082439  Chemical Structure
  60. GC71008 BBR-BODIPY BBR-BODIPY is a fluorescent probe that allows screening its interaction with the targeted cells. BBR-BODIPY  Chemical Structure
  61. GC68744 BC-?1258

    BC-1258 is an activator of F-box/LRR-repeat protein 2 (FBXL2) that stabilizes and upregulates FBXL2 levels. BC-1258 induces apoptosis in tumor cells and significantly inhibits tumor formation in mice.

    BC-?1258  Chemical Structure
  62. GC16516 BCH

    2-amino-2-Norbornanecarboxylic Acid

    BCH (BCH) is a selective and competitive inhibitor of large neutral amino acid transporter 1 (LAT1) significantly inhibit cellular uptake of amino acids and mTOR phosphorylation, which induces the suppression of cancer growth and apoptosis. BCH  Chemical Structure
  63. GC63325 Bcl-xL antagonist 2 Bcl-xL antagonist 2 is a potent, selective, and orally active antagonist of BCL-XL with an IC50 and Ki of 0.091 μM and 65 nM, respectively. Bcl-xL antagonist 2 promotes the apoptosis of cancer cells. Bcl-xL antagonist 2 has the potential for the research of the chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL). Bcl-xL antagonist 2  Chemical Structure
  64. GC62599 BCL6-IN-4 BCL6-IN-4 is a potent B-cell lymphoma 6 (BCL6) inhibitor with an IC50 of 97 nM. BCL6-IN-4 has anti-tumor activities. BCL6-IN-4  Chemical Structure
  65. GC68012 BCL6-IN-7 BCL6-IN-7  Chemical Structure
  66. GC10721 BDA-366 BDA-366 is a potent Bcl2 antagonist (Ki = 3.3 nM), binding Bcl2-BH4 domain with high affinity and selectivity. BDA-366 induces conformational change in Bcl2 that abrogates its antiapoptotic function, converting it from a survival molecule to a cell death inducer. BDA-366 suppresses growth of lung cancer cells. BDA-366  Chemical Structure
  67. GC73928 BDM19 BDM19 binds and activates cytosolic BAX dimers, and prompts cell apoptosis either alone or in combination with BCL-2/BCL-XL inhibitor Navitoclax. BDM19  Chemical Structure
  68. GC42912 Becatecarin

    BMS 181176, BMY 27557, NSC 655649, XL 119

    Becatecarin is a water-soluble, diethylaminoethyl analog of the antineoplastic antibiotic rebeccamycin. Becatecarin  Chemical Structure
  69. GC68369 Belantamab

    GSK2857914

    Belantamab  Chemical Structure
  70. GC72851 Belapectin

    GR-MD-02

    Belapectin (GR-MD-02) is a Galectin-3 (Gal-3) inhibitor. Belapectin  Chemical Structure
  71. GC65031 Belimumab Belimumab (LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab  Chemical Structure
  72. GC49042 Benastatin A A bacterial metabolite with diverse biological activities Benastatin A  Chemical Structure
  73. GC64354 Bendamustine Bendamustine (SDX-105 free base), a purine analogue, is a DNA cross-linking agent. Bendamustine activates DNA-damage stress response and apoptosis. Bendamustine has potent alkylating, anticancer and antimetabolite properties. Bendamustine  Chemical Structure
  74. GC10744 Bendamustine HCl

    SDX-105

    Bendamustine HCl (SDX-105), a purine analogue, is a DNA cross-linking agent. Bendamustine HCl activats DNA-damage stress response and apoptosis. Bendamustine HCl has potent alkylating, anticancer and antimetabolite properties. Bendamustine HCl  Chemical Structure
  75. GC46914 Bendamustine-d4 (hydrochloride) A neuropeptide with diverse biological activities Bendamustine-d4 (hydrochloride)  Chemical Structure
  76. GC49781 Benomyl

    NSC 263489

    A carbamate pesticide Benomyl  Chemical Structure
  77. GC62451 Benpyrine Benpyrine is a highly specific and orally active TNF-α inhibitor with a KD value of 82.1 μM. Benpyrine  Chemical Structure
  78. GC74515 Benufutamab

    GEN1029

    Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab  Chemical Structure
  79. GC49403 Benzarone

    L 2197, NSC 82134

    An active metabolite of benzbromarone Benzarone  Chemical Structure
  80. GC14930 Benzbromarone

    MJ10061, NSC 85433

    TMEM16A/B calcium-activated chloride channel (CaCC) blocker Benzbromarone  Chemical Structure
  81. GN10520 Benzoylpaeoniflorin Benzoylpaeoniflorin  Chemical Structure
  82. GC38683 Benzyl isothiocyanate Benzyl isothiocyanate is a member of natural isothiocyanates with antimicrobial activity. Benzyl isothiocyanate  Chemical Structure
  83. GN10358 Berbamine hydrochloride Berbamine hydrochloride  Chemical Structure
  84. GN10539 Bergenin

    (-)-Bergenin, Cuscutin, NSC 661749

    Bergenin  Chemical Structure
  85. GC42925 Berteroin

    5-Methylthiopentyl isothiocyanate

    Berteroin is a sulforaphane analog found in cruciferous vegetables including Chinese cabbage, rucola salad leaves, and mustard oil. Berteroin  Chemical Structure
  86. GC10734 Beta-Lapachone

    ARQ 501, NSC 26326, NSC 629749, SL 11001

    Beta-Lapachone (ARQ-501;NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression. Beta-Lapachone  Chemical Structure
  87. GC20142 Beta-Sitosterol

    β-Sitosterol (purity>98%); 22,23-Dihydrostigmasterol (purity>98%))

    Beta-Sitosterol is a plant sterol with multiple biological activities, including anti-inflammatory, anti-tumor, antipyretic and immunomodulatory activities. Beta-Sitosterol  Chemical Structure
  88. GC35504 Beta-Zearalanol Beta-Zearalenol is an mycotoxin produced by Fusarium spp, which causes apoptosis and oxidative stress in mammalian reproductive cells. Beta-Zearalanol  Chemical Structure
  89. GC70742 Betamethasone-d5-1 Betamethasone-d5-1 is deuterium labeled Betamethasone. Betamethasone-d5-1  Chemical Structure
  90. GN10632 Betulin

    (+)-Betulin, NSC 4644, Trochol

    Betulin  Chemical Structure
  91. GC10480 Betulinic acid

    Lupatic Acid, NSC 113090

    Betulinic acid is a natural pentacyclic triterpenoid compound and an inhibitor of eukaryotic topoisomerase I with an IC50 value of 5 μM. Betulinic acid  Chemical Structure
  92. GC48477 Betulinic Acid propargyl ester An alkyne derivative of betulinic acid Betulinic Acid propargyl ester  Chemical Structure
  93. GC48504 Betulinic Aldehyde oxime

    Betulin 28-oxime

    A derivative of betulin Betulinic Aldehyde oxime  Chemical Structure
  94. GC48520 Betulonaldehyde

    (+)-Betulonal, Betulonic Aldehyde

    A pentacyclic triterpenoid Betulonaldehyde  Chemical Structure
  95. GC73940 BFC1108 BFC1108 is a small molecule Bcl-2 functional converter. BFC1108  Chemical Structure
  96. GC74043 Bfl-1-IN-2 Bfl-1-IN-2 (Compound 13) is a reversible and covalent inhibitor of Bfl-1 (IC50: 4.3 μM). Bfl-1-IN-2  Chemical Structure
  97. GC12074 BG45 Novel HDAC3-selective inhibitor BG45  Chemical Structure
  98. GC68757 BH3 hydrochloride

    BH3 hydrochloride is a peptide that can penetrate the blood-brain barrier. It induces cell apoptosis by directly activating pro-apoptotic Bax/Bak or neutralizing anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-XL, Bcl-w, mcl1 and A-1) through binding to the BH3 domain.

    BH3 hydrochloride  Chemical Structure
  99. GC18136 BH3I-1

    BHI1; BH 3I1

    Bcl-2 or Bcl-XL inhibitor BH3I-1  Chemical Structure
  100. GC35511 BI-0252 BI-0252 is an orally active, selective MDM2-p53 inhibitor with an IC50 of 4 nM. BI-0252 can induce tumor regressions in all animals of a mouse SJSA-1 xenograft, with concomitant induction of the tumor protein p53 (TP53) target genes and markers of apoptosis. BI-0252  Chemical Structure
  101. GC17828 BI-847325 dual inhibitor of MEK and Aurora kinases BI-847325  Chemical Structure

Items 401 to 500 of 2711 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7

Set Descending Direction